Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Invitation to Roche Analyst Event at ASCO 2017 Freitag, 28. April 2017 - 10:02

Investor Update

E2498B80-83EC-7344-8D76-E8C28EC1C69F.jpg
 

Invitation to Roche Analyst Event at ASCO 2017

divider.png

Monday, 5 June 2017, 5:15pm CDT

We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (2 – 6 June 2017).

Meeting information
Date: 
Monday, 5 June 2017

Time:
4:45pm Registration desk opens
5:15pm Start of meeting
6:45pm End of meeting followed by a buffet reception

Venue
Marriott Downtown Chicago
Marriott Ballroom (Level 4)
540 North Michigan Avenue
60611 Chicago
>map

To register for the event, please follow the link (Password: Analyst2017).The registration will close on Friday, 2 June 2017.

Alternatively a live video webcast can be accessed via http://ir.roche.com

The presentation slides will be available from the IR website at http://ir.roche.com following to the closure of the ASCO meeting. 

A replay of the webcast will be available on demand on the Roche website. > click here

Best regards,

Karl Mahler
Head of Investor Relations

Sabine Borngräber
Investor Relations Officer

 
 

Roche Investor Relations

Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com                 

Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com 

Dr. Birgit Masjost 
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com

Dr. Sabine Borngräber 
Phone: +41 61 68-88027 
e-mail: sabine.borngraeber@roche.com 

Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com 

Dr. Susann Weissmüller 
Phone: +41 61-68-75619 
e-mail: susann.weissmueller@roche.com


Investor Relations North America

Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com           

Loren Kalm 
Phone: +1 650 225 3217 
e-mail: kalm.loren@gene.com